Shares of BioNTech SE have moved -4.2% today, and are now trading at a price of $147.2. In contrast, the S&P 500 index saw a 0.6% change. Today's trading volume is 362,772 compared to the stock's average volume of 972,777.
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. Based in Mainz, Germany the company has 3,082 full time employees and a market cap of $35,699,421,184.
The company is now trading -34.26% away from its average analyst target price of $223.91 per share. The 14 analysts following the stock have set target prices ranging from $149.47 to $314.09, and on average give BioNTech SE a rating of buy.
A string of strong margins growth bodes well for the company's future:
Date Reported | Revenue ($ MM) | Cost of Revenue ($ MM) | Gross Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2021-12-31 | 18,977 | 3,861 | 79.66 | 273.06 |
2020-12-31 | 482 | 704 | -46.03 | 63.04 |
2019-12-31 | 109 | 244 | -124.54 | n/a |